Daftar Pustaka

1. Meekin DSM, Mannel RS, Saia PD. The adnexal mass, 9 ed. In : Saia PJD, Cresman WT,
editors. Clinical Gynecology. New York: Elsevier Saunders, 2017:273.
2. Panduan Praktik Klinik Bagian Obstetri dan Ginekologi RSUD Dr. Kariadi Semarang.
Neoplasm Ovarium. Semarang: RS Dr. Kariadi, 2015.
3. Kanker Ovarium Protap HOGI. Obgynmag. Jakarta, 2011.
4. Akturk E, Karaca RE, Dede M, et al. Comparison of four malignancy risk indicies in detection
of malignant ovarium mass. Journal of Gynecology Oncolgy 2011. 3.
5. Zivanovix O, Sima CS, Ionsonos A, Bell-McGuinn K, P. J. Sabbatini, Leitao MM. Exploratory
analysis of serum CA-125 response to surgery and the risk of relapse in patient with FIGO
stage IIIC ovarian cancer. Gynecology Oncology 2009 115, 2009: 209-214;115:209-214.
6. Gentry-Maharaj A, Menon U. Best Practice & Research Clinical Obstetrics and Gynecology,
2012.
7. Fauzan R. Gambaran faktor risiko penggunaan kontrasepsi terhadap angka kejadian kanker
ovarium di RSUPN Dr. Cipto Mangunkusumo Jakarta berdasarkan pemeriksaan histopatologik.
Jakarta : University of Indonesia, 2011.
8. Epitelial Ovarian Cancer. In: Hoffman BL, Schorge JO, Schaffer JI, Halvorson LL, Bradshaw
KD, Cunningham FG, editors. Williams Gynecology. New York: McGraw 2012:853-873
9. Gynecologic Malignancies Posket Guideline 2016. Newly Diagnosed and Relapsed Epithelial
Ovarian Carcinoma. European Society for Medical Oncology, 2016.
10. NCCN Clinical Practice Guideline in Oncology. Ovarian Cancer Including Fallopian Tuber
Cancer and Primary Peritoneal Cancer. Washington: National Comprehensive Cancer
Network, 2018.